Biomarkers of neurotoxic shellfish poisoning.

Abstract

Urine specimens from patients diagnosed with neurotoxic shellfish poisoning (NSP) were examined for biomarkers of brevetoxin intoxication. Brevetoxins were concentrated from urine by using solid-phase extraction (SPE), and analyzed by enzyme-linked immunosorbent assay (ELISA) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Urine extracts were fractionated by LC, and fractions analyzed for brevetoxins by ELISA. In subsequent LC-MS/MS analyses, several brevetoxin metabolites of B-type backbone were identified, with elution profiles consistent with those of ELISA. The more abundant brevetoxin metabolites in urine were characterized structurally by LC-MS/MS. With the exception of BTX-3, brevetoxin metabolites in urine differed from those found in shellfish and in shellfish meal remnants. Proposed structures of these major urinary metabolites are methylsulfoxy BTX-3, 27-epoxy BTX-3, and reduced BTX-B5. BTX-3 was found in all specimens examined. BTX-3 concentrations in urine, as determined by LC-MS/MS, correlated well with composite toxin measurements by ELISA (r(2)=0.96). BTX-3 is a useful biomarker for confirmation of clinical diagnosis of NSP.

DOI: 10.1016/j.toxicon.2008.04.175

Cite this paper

@article{Abraham2008BiomarkersON, title={Biomarkers of neurotoxic shellfish poisoning.}, author={Ann Mary Abraham and Steven M. Plakas and Leanne J. Flewelling and Kathleen R El Said and Edward L. E. Jester and Hudson R. Granade and K. D. White and Robert W. Dickey}, journal={Toxicon : official journal of the International Society on Toxinology}, year={2008}, volume={52 2}, pages={237-45} }